Posted by on April 18, 2015 - 9:35am

We are well aware that cigarette smoking has a direct link to lung cancer.  Did you know that the latest Surgeon General's report identified 21 other diseases that have a causal relationship to cigarettes?

The list included 12 types of cancer, 6 categories of cardiovascular disease, diabetes, chronic obstructive pulmonary disease, and some pneumonias.  But a new report put  out by the American Heart Association, the National Cancer Institute and several major medical centers that pooled data on millions of subjects of both sexes and age 55 years and older found other concerns for smokers. In this study,  mortality was followed from 2000 to 2011.

 There were 181,377 deaths overall---19% in smokers and 14% in non smokers. The study reconfirmed the increase morality due to smoking in the conditions listed above.    However, 17% of the smokers with increased mortality helped identify new conditions impacted by smoking:   renal failure, intestinal ischemia, hypertensive heart disease, infections, various respiratory conditions, breast cancer and prostate cancer---conditions not part of the earlier "21". 

While the study provides a more complete lists of conditions increased due to smoking, it also reinforces the fact that the rate of death from almost any cause was two to three time higher in current smokers when compared to non smokers.  While more study is needed to rule our other behaviours and determine how smoking effects treatment, the study demonstrates how important it is to reduce smoking espeically in young people.   Smoking also impacts one's  quality of life and will often cause mortality due to chronic conditions a decade earlier in smokers.  It sure makes sense to put those cigarettes away.

 

 

Posted by on July 27, 2011 - 6:14am

A new study uncovers a brain mechanism that could be targeted for new medications designed to help people quit smoking without gaining weight. This research, funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, shows that a specific subclass of brain nicotinic receptor is involved in nicotine’s ability to reduce food intake in rodents. Prior research shows that the average weight gain after smoking is less than 10 pounds, but fear of weight gain can discourage some people who would like to quit.

In the study, to be published in the June 10 issue of Science, researchers found that a nicotine-like drug, cytisine, specifically activated nicotinic receptors in the hypothalamus — a brain center that controls feeding. This resulted in the activation of a circuit that reduced food intake and body fat in a mouse model. This effect was very specific, since a drug that prevented cytisine from binding to its hypothalamic receptors blocked the reduction in food intake.

Through the use of tobacco, nicotine is one of the most heavily used addictive drugs and the leading preventable cause of disease, disability, and death in the United States. Despite the well-documented health costs of smoking, many smokers report great difficulty quitting.

"These mouse models allow us to explore the mechanisms through which nicotine acts in the brain to reduce food intake," said Dr. Marina Picciotto, of Yale University, New Haven, Conn. and senior author for the article.

"These results indicate that medications that specifically target this pathway could alleviate nicotine withdrawal as well as reduce the risk of overeating during smoking cessation," said NIDA Director Dr. Nora D. Volkow. "Although more research is warranted, such a highly selective compound might be more effective than drugs that act on more than one type of nicotinic receptor."

For information on tips to maintain a healthy weight while quitting smoking go to Forever Free: Smoking and Weight, a publication of the National Cancer Institute. For additional information on resources to help quit smoking, go HERE

The study can be found online at: www.sciencemag.org/.